FORCE Blog

This blog will cover topics of interest that affect our community. Unless otherwise stated, the blog articles will be written by Sue Friedman, Executive Director of FORCE.

| More

Archive for 2020

March 31, 2020

Dealing with an Extra Helping of Stress

“Driving into the skid means accepting the anxiety you’re feeling for what it is and experiencing the fluttery feeling in your stomach,” Hurley said

March 4, 2020

Learning I Had Lynch Syndrome Helped Save My Life

After five years with no evidence of disease (NED), Wenora Johnson’s colon cancer returned and her oncologist recommended genetic testing. She tested positive for Lynch syndrome, an inherited syndrome associated with a genetic predisposition to different types of cancer. Today, Wenora is a three-time cancer survivor, advocate and FORCE volunteer. With Lynch syndrome Awareness Day … + read more

February 19, 2020

New Medicare Genetic Testing Policy: What Does It Mean to Me?

Recently, the Centers for Medicare and Medicaid Services (CMS) released their final National Coverage Determination (NCD) on a type of genetic testing called next-generation sequencing (NGS), which enables laboratories to examine multiple genes at once. The policy paves the way for national coverage of tumor biomarker testing and multigene panel testing for hereditary cancer in specific … + read more

January 28, 2020

FORCE Supports Broader Access to Genetic Counseling

by Lisa Schlager Genetic testing is an increasingly important and complex service that can inform medical decisions and improve health outcomes. National standard-of-care guidelines recommend genetic counseling with a qualified expert before and after genetic testing. FORCE agrees that talking to a healthcare professional who has expertise in cancer genetics before and after genetic testing … + read more

January 6, 2020

New PARP Inhibitor Approval for Pancreatic Cancer

On December 27th, the Food and Drug Administration (FDA) approved olaparib (Lynparza) – a type of targeted therapy known as a PARP inhibitor—for treatment of metastatic pancreatic cancer in people with a BRCA mutation.

Connect with others.

Call our Helpline

Our helpline offers peer support for people concerned about hereditary cancer. All calls are confidential. Call any time.

Join a Local Group

FORCE has outreach groups throughout the United States and in Essex, United Kingdom that meet periodically to offer peer support, and share resources.

FORCE:Facing Our Risk of Cancer Empowered